# Lucile Salter Packard Children's Hospital Stanford Medicine Fertility and Reproductive Health – FDA Inspection, Apr 27, 2023

Source: https://www.keypedia.com/records/fda_inspections/lucile-salter-packard-childrens-hospital-stanford-medicine-fertility-and-reproductive-health/89340b69-eebb-4bc8-ab62-a623fcb46ae3
Source feed: FDA_Inspections

> FDA inspection 1203818 of Lucile Salter Packard Children's Hospital Stanford Medicine Fertility and Reproductive Health, April 27, 2023. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 1271. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1203818
- Company Name: Lucile Salter Packard Children's Hospital Stanford Medicine Fertility and Reproductive Health
- Inspection Date: 2023-04-27
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1267717 - 2025-04-18
- FDA Inspection 1002842 - 2017-02-28
- FDA Inspection 860761 - 2014-01-07
- FDA Inspection 811732 - 2012-12-19
- FDA Inspection 681080 - 2010-09-22

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/shelley-h-beausoleil/1212116b-e24d-4bbc-a27a-5c16334d573e)

Company: https://www.keypedia.com/companies/lucile-salter-packard-childrens-hospital-stanford-medicine-fertility-and-reproductive-health/cdffa0c9-0146-4e58-82eb-0b69d70e68f1

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
